Gene · 4585
Papers4,232
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,201 to 1,220 of 4,232
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Upgrade of an old drug: Auranofin in innovative cancer therapies to overcome drug resistance and to increase drug effectiveness. | Med Res Rev | 2022 | 34850406 | PubTator, text mining | PubMed |
| Intracranial mesenchymal tumors with FET-CREB fusion are composed of at least two epigenetic subgroups distinct from meningioma and extracranial sarcomas. | Brain Pathol | 2022 | 34821426 | PubTator, text mining | PubMed |
| Identification of a genetic signature enriching for response to ibrutinib in relapsed/refractory follicular lymphoma in the DAWN phase 2 trial. | Cancer Med | 2022 | 34791836 | PubTator, text mining | PubMed |
| Molecular characterization of dysplasia-initiated colorectal cancer with assessing matched tumor and dysplasia samples. | Ann Coloproctol | 2022 | 34788527 | PubTator, text mining | PubMed |
| Philadelphia-like acute lymphoblastic leukemia: Characterization in a pediatric cohort in a referral center in Colombia. | Cancer Rep (Hoboken) | 2022 | 34787376 | PubTator, text mining | PubMed |
| MicroRNA-204 attenuates oxidative stress damage of renal tubular epithelial cells in calcium oxalate kidney-stone formation via MUC4-mediated ERK signaling pathway. | Urolithiasis | 2022 | 34783868 | PubTator, text mining | PubMed |
| Nuclear accumulation of KPNA2 impacts radioresistance through positive regulation of the PLSCR1-STAT1 loop in lung adenocarcinoma. | Cancer Sci | 2022 | 34773335 | PubTator, text mining | PubMed |
| Epithelial barrier dysfunction in ocular allergy. | Allergy | 2022 | 34757631 | PubTator, text mining | PubMed |
| Diagnosis of soft tissue tumors using immunohistochemistry as a surrogate for recurrent fusion oncoproteins. | Semin Diagn Pathol | 2022 | 34750023 | PubTator, text mining | PubMed |
| Effects of Long-Term In Vitro Expansion on Genetic Stability and Tumor Formation Capacity of Stem Cells. | Stem Cell Rev Rep | 2022 | 34738209 | PubTator, text mining | PubMed |
| Vaping and Lung Inflammation and Injury. | Annu Rev Physiol | 2022 | 34724436 | PubTator, text mining | PubMed |
| Can miRNAs be useful biomarkers in improving prognostic stratification in endometrial cancer patients? An update review. | Int J Cancer | 2022 | 34706070 | PubTator, text mining | PubMed |
| Pleomorphic Onychomatricoma: A Mimicker of Malignancy. | Acta Derm Venereol | 2022 | 34694416 | PubTator, text mining | PubMed |
| The emerging PRRX1-NCOA fibroblastic neoplasm: a combined reappraisal of published tumors and two new cases. | Virchows Arch | 2022 | 34647172 | PubTator, text mining | PubMed |
| Metabolic adaptation drives arsenic trioxide resistance in acute promyelocytic leukemia. | Blood Adv | 2022 | 34625794 | PubTator, text mining | PubMed |
| Head and Neck Low-Grade Fibromyxoid Sarcoma: A Clinicopathologic Study of 15 Cases. | Head Neck Pathol | 2022 | 34559373 | PubTator, text mining | PubMed |
| The mucin protein MUCL1 regulates melanogenesis and melanoma genes in a manner dependent on threonine content. | Br J Dermatol | 2022 | 34545566 | PubTator, text mining | PubMed |
| Viral respiratory infections and air pollutants. | Air Qual Atmos Health | 2022 | 34539932 | PubTator, text mining | PubMed |
| Mucin 5AC Serves as the Nexus for β-Catenin/c-Myc Interplay to Promote Glutamine Dependency During Pancreatic Cancer Chemoresistance. | Gastroenterology | 2022 | 34534538 | PubTator, text mining | PubMed |
| Signet ring cell cancer of stomach and gastro-esophageal junction: molecular alterations, stage-stratified treatment approaches, and future challenges. | Langenbecks Arch Surg | 2022 | 34505199 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4585/papers?page=61